Cinevista Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sastasundar Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Alankit Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Alembic Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates
Linde India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pressman Advertising Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
M K Proteins Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Hitech Corporation Limited has informed the Exchange about Loss of Share Certificates
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2022, titled Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single‐Dose Pre‐Filled Syringe.
Hotel Rugby Limited has submitted to the Exchange a Copy of Letter of Offer of Hotel Rugby Limited Target Company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
